Dna X SONM
NASDAQ SONM
$4.50 -0.18 (-3.85%)
As of: Oct 1, 2026 · 10:18 AM EDT

Dna X (SONM) EBIT Margin (2018 - 2025)

Updated

Dna X (SONM) recorded EBIT Margin of -6.99% in FY2026.

Analysis

Dna X (SONM) EBIT Margin (2018 - 2025) Analysis & Trends

Starting with FY2018, Dna X's EBIT Margin history includes 8 years.

  • Annual EBIT Margin has a five-year change of +62.64 percentage points (FY2021 to FY2026).
  • The FY2026 figure is the lowest annual EBIT Margin since FY2022.
  • Per Business Quant data, SONM's EBIT Margin was -5.32% in FY2024 (-5.87 pp), 0.55% in FY2023 (+21.01 pp) and -20.46% in FY2022 (+49.17 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Robinhood Markets 101.14 Bn 82.23 Bn - 66.36%
2 Bank of New York Mellon 98.14 Bn 37.51 Bn - 119.30%
3 Cme 94.12 Bn 94.12 Bn - 64.89%
4 Intercontinental Exchange 85.35 Bn 79.16 Bn - 38.52%
5 Nasdaq 51.71 Bn 49.14 Bn 1.50 Bn 28.12%
6 State Street 47.94 Bn 47.94 Bn - 83.30%
7 Interactive Brokers 38.49 Bn 31.95 Bn - 138.98%
8 Northern Trust 30.99 Bn 30.99 Bn - 191.07%
9 Cboe Global Markets 28.76 Bn 20.41 Bn 731.60 Mn 32.99%
10 Dna X 6.80 Mn 1.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -24.55%
Jun 30, 2025 -13.15%
Mar 31, 2025 -5.20%
Dec 31, 2024 56.29%
Sep 30, 2024 -15.82%
Jun 30, 2024 -56.18%
Mar 31, 2024 -16.03%
Dec 31, 2023 -9.34%
Sep 30, 2023 2.50%
Jun 30, 2023 2.78%
Mar 31, 2023 1.29%
Dec 31, 2022 -4.39%
Sep 30, 2022 -9.41%
Jun 30, 2022 -35.30%
Mar 31, 2022 -53.42%
Dec 31, 2021 -73.71%
Sep 30, 2021 -74.23%
Jun 30, 2021 -54.26%
Mar 31, 2021 -73.94%
Dec 31, 2020 -47.11%
API Access

Dna X EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=SONM&period=max&api_key=YOUR_API_KEY